NewsBenzingaJohnson & Johnson To Present New Findings On IMAAVY For Treatment Of Generalized Myasthenia Gravis Across 15 Novel Abstracts At 2026 MGFA Scientific Session And AANEM Annual Meeting Johnson & Johnson To Present New Findings On IMAAVY For Treatment Of Generalized Myasthenia Gravis Across 15 Novel Abstracts At 2026 MGFA Scientific Session And AANEM Annual Meeting Benzinga 2026.09.29 12:09 (GMT+0) Open on Benzinga Other news Wall Street Says the Muse AI Catalyst for Twilio Stock Is More Hype Than Substance Trump Signs Executive Order Launching America.gov to Unify Access to Federal Services State Street's Quarterly Earnings Preview: What You Need to Know JP Morgan Maintains Overweight on Yum Brands, Lowers Price Target to $150 Blockworks Launches On-Chain Intelligence Product Intel, Integrating Messari Data and Multi-Agent Analysis JP Morgan Maintains Neutral on US Foods Holdings, Lowers Price Target to $98
Blockworks Launches On-Chain Intelligence Product Intel, Integrating Messari Data and Multi-Agent Analysis
